Pharmaceutical Executive Daily: Novo Nordisk Files Lawsuit Against Eli Lilly

Jul 22, 06:47 PM
Headliner
Share
Subscribe

In today's Pharmaceutical Executive Daily, Novo Nordisk sues Eli Lilly over GLP-1 advertising it calls misleading, President Trump announces a phased tariff plan for imported generic drugs, and a new commentary argues pharma's AI investment is missing the areas of drug discovery where it matters most.

Share
Subscribe
Next
Pharmaceutical Executive Daily: Eli Lilly Reports Positive Results from Two Phase III Trials
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
by Pharmaceutical Executive